A study to evalute iron metabolism by hepcidin-25 in patients on hemodialysis treated with epoetin beta pegol once-monthly or twice--monthly - A study to evalute iron metabolism by hepcidin-25 in patients on hemodialysis treated with epoetin beta pegol once-monthly or twice--monthly

kanazawa medical university medical research institute,Division of Aging Research0 个研究点目标入组 24 人开始时间: 2014年1月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.patients who do not accept this study 2.patients who have allergy for ESA 3.patients who have uncontrollable high blood pressure 4.patients with factors that could have a clear impact on hemoglobin concentration, such as infectious diseases, malignant tumors, bleeding of moderate or more 5.women who are pregnant,breastfeeding,possibly pregnant,or not willing to use birth control in the period leading up to the end of the study at the time of obtaining informed consent 6.patients who received red bllod cell transfusion within 3 months before enrollment 7.patients who are judged ineligible by the physician in charge

发起方

kanazawa medical university medical research institute,Division of Aging Research